Navigation Links
Kinovate Life Sciences Launches Nittophase?High Performance Solid Support For Oligonucleatide Synthesis

artner to both oligonucleotide manufacturers and drug development companies by providing NittoPhase? a new support with superlative performance at a significantly reduced unit cost. In this way we see considerable potential to make it possible for players of all scales in this industry to meet both long and short term objectives of cost savings, and the eventual development of oligonucleotide drugs that are affordable to patients,?stated Dr. Kenji Matsumoto, President of Kinovate Life Sciences, Inc. “Through our strong collaborative relationship with Isis Pharmaceuticals, we have had access to the very highest standard of technical and analytical resources to ensure that NittoPhase?will deliver unmatched performance.?/p>

“Our internal testing and analysis of NittoPhase?has clearly validated this product in terms of technical and cost performance. As a result of our partnership with Nitto Denko Corporation, Isis is pleased to incorporate NittoPhase?into its own drug development operations going forward,?said B. Lynne Parshall, Executive Vice President and Chief Financial Officer of Isis Pharmaceuticals. “We look forward to participating in the success of NittoPhase? Our product development partnership with Nitto Denko is another example of how Isis has used its expertise in RNA-based drug discovery and development to work with partners in bringing innovative products to the market.?/p>
'"/>

Source:PRWeb


Page: 1 2

Related biology news :

1. Affymetrix Licenses Microfluidics Technology From Caliper Life Sciences
2. TrueBlue Archive Will Store Raw Life Sciences Data for Proteomics and Drug Testing
3. Sangamo BioSciences demonstrates its ZFP treatment protects cells from HIV infection
4. Affymetrix Launches New Globin-Reduction Kits and Protocol Developed with PreAnalytiX
5. IMF Launches World’s First DNA Database for Myeloma Patients
6. Invitrogen Launches i-Path -- A Unique Systems Biology Platform at BIO 2005
7. UCLA Study Shows One-Third of Drug Ads in Medical Journals Do Not Contain References Supporting Medical Claims
Post Your Comments:
(Date:10/3/2008)...loped conspicuous traits produced by melanin pigme...pes in some birds and fishes). These traits are us... contribute to increase the mating opportunities. ... depends on the fact that they transmit honest inf...ld be only assured by the fact that producing or m...
(Date:10/3/2008)...evolutionary biologists are still debating this qu...journal PLoS ONE, supports the view that the fir... thousands of years before the French Revolution, ...hrough intense power struggle and their origin had...ls living in groups, including hyenas, meerkats, a...
(Date:10/3/2008)...prevailing thought, a study in mice has found that...-burning" can actually increase energy expenditure...l findings, appearing this week in the JBC, migh..., Humans and other warm-blooded animals need to ...emperature, and it,s currently believed that an in...
(Date:10/2/2008)...om their birthplace to their work site, they seque...ck of exceptionally strong proteins known as the e... the October 3 issue of Cell , scientists at the ...iversity show that a molecule, called ACF7, helps ... findings that could have implications for underst...
Breaking Biology News(10 mins):Traits produced by melanin may signal the bearer's capacity to combat free radicals 2Egalitarian revolution in the Pleistocene? 2Egalitarian revolution in the Pleistocene? 3Egalitarian revolution in the Pleistocene? 4Making metabolism more inefficient can reduce obesity 2Scientists identify a molecule that coordinates the movement of cells 2Tioga Pharmaceuticals Asimadoline Demonstrates Positive Results in a Phase 2b Clinical Trial for the Treatment of Irritable Bowel Syndrome 2148 1Tioga Pharmaceuticals Asimadoline Demonstrates Positive Results in a Phase 2b Clinical Trial for the Treatment of Irritable Bowel Syndrome 2148 2Tioga Pharmaceuticals Asimadoline Demonstrates Positive Results in a Phase 2b Clinical Trial for the Treatment of Irritable Bowel Syndrome 2148 3Tioga Pharmaceuticals Asimadoline Demonstrates Positive Results in a Phase 2b Clinical Trial for the Treatment of Irritable Bowel Syndrome 2148 4Mayo Clinic Research Shows U S Intensive Care Units Prevention of Pneumonia in Critically ill Patients Generally Strong 3B Identifies Area of Improve 19954 1Mayo Clinic Research Shows U S Intensive Care Units Prevention of Pneumonia in Critically ill Patients Generally Strong 3B Identifies Area of Improve 19954 2Mayo Clinic Research Shows U S Intensive Care Units Prevention of Pneumonia in Critically ill Patients Generally Strong 3B Identifies Area of Improve 19954 3Perforomist comparable pharmacokinetic and pharmacodynamic profile to DPI formulation 19951 1Perforomist comparable pharmacokinetic and pharmacodynamic profile to DPI formulation 19951 2When It comes to Matters of the Heart Almonds Are a Multi Tasker 19947 1When It comes to Matters of the Heart Almonds Are a Multi Tasker 19947 2When It comes to Matters of the Heart Almonds Are a Multi Tasker 19947 3When It comes to Matters of the Heart Almonds Are a Multi Tasker 19947 4When It comes to Matters of the Heart Almonds Are a Multi Tasker 19947 5
... patients may soon be possible, thanks to a discov...ia neuroscience researchers who have found a new s... chemicals are lost from brain cells during stroke...ims. , The findings were published recently in Sc...ext month,s issue of Nature Reviews Neuroscience. ...
... announced Quebec,s first successful combined hear...ge 54 years, was transferred from the Institut de ...C. The patient received his new heart and liver du...discharged 10 days later. The complex procedure in...re professionals. The MUHC conducts the most organ...
...en who are extremely obese may be underestimated a...nce of hypertension, diabetes, and high cholestero... to a study in the July 5 issue of JAMA. , Obesity...dy mass index (BMI) of at least 30. BMI is calcula...ters squared. However, three categories of obesity...
...arbon dioxide from fossil fuel burning are dramati...ine organisms, including corals, that secrete skel...A landmark report released today summarizes the kn...e on these organisms, known as marine calcifiers, ... extent of the impacts. , "It is clear that seawat...
Other Biology News:UBC researchers find stroke death channel 2MUHC announces a transplant first in Quebec 2Higher levels of obesity associated with greater health risks 2Higher levels of obesity associated with greater health risks 3Report warns about carbon dioxide threats to marine life 2Report warns about carbon dioxide threats to marine life 3
(Date:10/3/2008)...Symbol: MS, EDMONTON, Oct. 3 /PRNewswire-FirstCal...loper in the treatment of multiple sclerosis (MS),...Monitoring Board (DSMB) for the,Company,s U.S. piv...8298),in patients with secondary progressive MS ha... the trial continue as per the protocol., This wa...
(Date:10/3/2008)...or Ap3ana, CTI,s ,personalized medicine, venture, ...erapeutics, Inc. (CTI),(Nasdaq: CTIC ) announced ...t recently President and COO of a Tyr Pharma and f...mics Institute of the Novartis Research,Foundation... Bresso, Italy,CTI Europe currently conducts the ...
(Date:10/2/2008)...2 /- Helix BioPharma,Corp. ... its private,placement announced on September 30, ...ss proceeds totaling CDN$11,424,000., Each unit c...mmon share,purchase warrant, with each whole commo...urchase, subject to adjustment, one common share a...
(Date:10/2/2008)...Provides Business Update to Investors, WILMINGTON...today at an,investor conference, DuPont Vice Presi...ny,s plans to bring its two advanced biofuels prog... technical progress toward the,commercialization o...stocks,economically into biofuels., "Biobutanol a...
Breaking Biology Technology:BioMS Medical's phase III U.S. multiple sclerosis trial receives positive safety review from Data Safety Monitoring Board 2Former Scientific Director at Genomics Institute of Novartis Research Foundation Named President of Cell Therapeutics Europe 2Former Scientific Director at Genomics Institute of Novartis Research Foundation Named President of Cell Therapeutics Europe 3Former Scientific Director at Genomics Institute of Novartis Research Foundation Named President of Cell Therapeutics Europe 4Helix Biopharma Closes $11.4 Million Private Placement 2DuPont Meeting Significant 2008 Milestones in Progressing Advanced Biofuels 2DuPont Meeting Significant 2008 Milestones in Progressing Advanced Biofuels 3
...ke a man on the hot seat, at least not in public. ...State of Wisconsin,s information technology consol...ubled project, now the subject of a state audit, d...t the Concourse Hotel. , , Miszewski Despite cr...ges facing the ambitious project are not unusual a...
...tor Vehicles has deployed a new facial recognition..., ,Preventing mischief in the issuance of driver,s...Phil Alioto, a fraud prevention specialist with th...right identification like a Social Security card o...e driver,s license issuing process to establish a ...
...hree of its advanced radiation therapy systems to ...mpany announced. , ,The H. Lee Moffitt Cancer Ce...y of South Florida in Tampa, will install three of...ting patients with it by August of this year. The ...member of the National Comprehensive Cancer Networ...
...passed a bill that will make it easier for Univers... discoveries, but two other bills endorsed by the ...during the remainder of the 2005-07 legislative se...bly and the State Senate enacted their respective ...e the process UW researchers use to bring their id...
Other Biology Technology:Miszewski touts benefits of IT integration 2Miszewski touts benefits of IT integration 3New DMV tool never forgets a face 2New DMV tool never forgets a face 3Leading cancer institute to install three TomoTherapy systems 2Legislature adopts one tech bill, leaves two others twisting 2Legislature adopts one tech bill, leaves two others twisting 3Legislature adopts one tech bill, leaves two others twisting 4
Mouse Monoclonal to L1 Cell Adhesion Molecule The L1CAM gene, which is located in Xq28, is involved in three distinct conditions: 1) HSAS (hydrocephalus-stenosis of the aqueduct of Sylvius); 2) MA
GolgiPlug from BD Biosciences Pharmingen
The Beacon 2000 One-Step FP Standardization Kit is used to demonstrate characteristic high and low fluorescence polarization values of fluorescein solutions to new users of the Beacon 2000 System. It
...with new technology incorporating the sophisticate...assed flexibility, the new Varian NMR System is un...today., ,The Varian NMR System features parall...hannel, providing pulse sequence programming power...
Biology Products: